In the high-stakes world of pharmaceutical research, where precision can save lives, Shalom Emmanuel is making waves. A Nigerian-born Ph.D. candidate at Texas Southern University, she’s gaining international acclaim for her pioneering work in drug metabolism and pharmacokinetics (DMPK), the science of how medicines work in the body. Her journey from Nigeria to Texas exemplifies how global talent drives American innovation, delivering safer drugs to patients worldwide.
Emmanuel’s research is both meticulous and transformative. Her 2025 paper in Metabolites, “Development and Validation of a Novel LC-MS/MS Method for Alvocidib Quantification,” introduced a technique that enhances how scientists measure drug safety, vital for therapies reaching millions. Her 2024 study in Molecules, “Species Differences in Ezetimibe Glucuronidation,” uncovered metabolic variations that could disrupt drug trials, earning citations in global pharmacology discussions. “Shalom’s work is setting new industry standards,” says Dr. Gao Song, her advisor at Texas Southern. “Her methods are reshaping how we design and test drugs.”
These achievements aren’t just academic. Published in Scopus-indexed journals like Metabolites, Molecules, and Analytical Methods, Emmanuel’s studies are shaping pharmaceutical practices. Her work’s global citations reflect its influence, positioning her among the top researchers in her field. “My goal is to make medicines safer by understanding exactly how they’re metabolized,” she says. “Each discovery moves us toward therapies that work for diverse populations.”
Beyond the lab, Emmanuel holds the Certified Forensic Chemistry Project Auditor (CFCPA) credential from the American Academy of Project Management, a rare distinction earned by fewer than 5% of applicants globally. This certification underscores her expertise in forensic analytics, ensuring drug data is as reliable as the science behind it. “It’s about accountability,” she notes. “Safe medicines depend on trustworthy data.”
Her leadership extends to mentoring and evaluation. In 2024, she served as a judge for Nigeria’s Wella Well Health Business Competition, assessing innovative health solutions by medical students. This role, uncommon for a graduate researcher, highlights her growing reputation as an authority in scientific innovation. “The students’ creativity was inspiring,” she says. “It shows innovation thrives in Nigeria and beyond.”
Emmanuel’s accolades tell a story of relentless excellence: First Place at Georgia Southern University’s 2021 Graduate Research Symposium, selected from hundreds of researchers; Helen Giddings Scholarships (2023-2024); a Dean’s Scholarship; and a $160,000 Ph.D. assistantship. She’s also a member of elite associations, American Association of Pharmaceutical Scientists (AAPS), American Society for Pharmacology and Experimental Therapeutics (ASPET), and American Association for the Advancement of Science (AAAS) each requiring outstanding achievements.
From Nigeria’s Landmark University to Texas Southern’s labs, Emmanuel bridges continents through science. Her collaborations with international teams ensure drugs meet stringent regulatory standards, impacting patients from Lagos to Los Angeles. “Science is universal,” she says. “Discoveries start in local labs but save lives globally.”
In a U.S. landscape hungry for STEM talent, Emmanuel’s story underscores the value of global innovators. Her work doesn’t just advance pharmaceuticals, it sets a benchmark for what dedication and precision can achieve. As she continues to redefine drug safety, her contributions remind us why the world’s best minds choose America to make a difference.
Learn more about Emmanuel’s work at Texas Southern University’s College of Pharmacy (www.tsu.edu/pharmacy) (www.tsu.edu/pharmacy).
Media Contact
Company Name: TSU
Contact Person: SHALOM EMMANUEL
Email: Send Email
Phone: (912) 220-0651
City: Houston
State: Texas
Country: United States
Website: www.tsu.edu/